Supercharged immune cells take on tough gynecologic cancers
NCT ID NCT05468307
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tested a new therapy called GC203 TIL in 26 people with advanced gynecologic tumors that had stopped responding to standard treatments. Doctors took immune cells from each patient's tumor, genetically modified them to be more powerful, and infused them back. The main goals were to check safety and see if the treatment could shrink tumors or slow disease progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- engineered immune cells (GC203 TIL)
- What this could lead to
- If it works, this could point toward a new treatment option for advanced gynecologic tumors that have not responded to standard therapies.
- What could go wrong
- This is a very early, small study (26 people) focused on safety. The treatment may not shrink tumors or could cause serious side effects. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED GYNECOLOGIC TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, 200000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Patient's own immune cells fight advanced cancer?
- Can chemo and radiation steal fertility? a massive study aims to find out
- Cancer patients face more treatment side effects from rare lung infections
- ICU delirium drug study pulled before starting
- Tiny study compares trazodone and quetiapine for ICU delirium – but was cut short
- Which surgery is better for uterine septum? new trial aims to find out